v3.25.2
Stockholders' Equity and Share-Based Compensation (Tables)
12 Months Ended
Apr. 26, 2025
Equity [Abstract]  
Schedule of Nonvested Restricted Stock and Restricted Stock Units Activity
A summary of non-vested restricted stock and restricted stock units for fiscal years 2025, 2024, and 2023 is as follows:
Year Ended
April 26, 2025April 27, 2024April 29, 2023
Number of Nonvested Shares Weighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Outstanding at beginning of year486 $5.95 617 $4.11 469 $5.65 
Granted318 13.19 159 9.85 360 3.15 
Vested(189)6.45 (280)3.92 (192)5.98 
Forfeited(15)6.71 (10)4.77 (20)4.98 
Outstanding at end of year600 $9.62 486 $5.95 617 $4.11 
Share-based Payment Arrangement, Option, Activity A summary of stock option activity under our 2015 Plan and 2020 Plan during the fiscal year ended April 26, 2025 is as follows:
Stock Options Weighted Average Exercise Price
Per Share
Weighted Average Remaining
Contractual Life (Years)
Aggregate Intrinsic Value
Outstanding as of April 27, 2024
1,635 $6.89 5.06$4,607 
Granted29 11.87 — — 
Cancelled or forfeited(165)— — — 
Exercised(598)8.66 — 3,594 
Outstanding as of April 26, 2025
901 $5.78 5.41$6,107 
   
Shares vested and expected to vest890 $5.78 5.38$6,031 
Exercisable as of April 26, 2025
530 $6.46 4.29$3,233 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table provides the weighted-average fair value of options granted and the related assumptions used in the Black-Scholes model:
Year Ended
April 26, 2025April 27, 2024April 29, 2023
Fair value of options granted$5.98 $4.92 $1.34 
Risk-free interest rate3.58 %4.37 %3.37 %
Expected volatility49.14 %46.28 %41.10 %
Expected life of option (in years)6.836.906.93
Share-based Compensation Expense
The following table presents a summary of the share-based compensation expense by equity type as follows:
Year Ended
April 26, 2025April 27, 2024April 29, 2023
Stock options$910 $420 $453 
Restricted stock and stock units1,591 1,177 1,153 
Employee stock purchase plans443 493 421 
$2,944 $2,090 $2,027 
A summary of the share-based compensation expense by classification in the Consolidated Statements of Operations for stock options, restricted stock, restricted stock units, and shares issued under the ESPP for fiscal years 2025, 2024, and 2023 is as follows:
Year Ended
April 26, 2025April 27, 2024April 29, 2023
Cost of sales$613 $452 $441 
Selling460 437 424 
General and administrative1,577 745 735 
Product design and development294 456 427 
$2,944 $2,090 $2,027